Clinical Trial Update: Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development

View source ↗

Summary

This completed clinical trial studied biomarkers in the immediate postnatal period of development in Spinal Muscular Atrophy; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Snippet

Sponsor: Ohio State University | Conditions: Spinal Muscular Atrophy (SMA) | Status: COMPLETED | Results posted: 2018-05-04